Elastrin Therapeutics

About:

Elastrin Therapeutics is a biotech company developing novel therapies to reverse cardiovascular disease.

Website: https://www.elastrin.com/

Twitter/X: elastrin

Top Investors: SC Launch, Inc., Starbloom Capital, KIZOO Technology Capital

Description:

Elastrin Therapeutics is a biotech startup with technologies to restore hardened and damaged arteries & tissue by targeting the elastic fiber that makes them work. The company's proprietary platform that targets and restores degraded elastin by removing the harmful calcification that stiffens arteries. The platform significantly improves the efficacy of drugs and eliminates side effects by combining particle design with elastin targeting.

Total Funding Amount:

$20.8M

Headquarters Location:

Simpsonville, South Carolina, United States

Founded Date:

2017-01-01

Contact Email:

info(AT)elastrin.com

Founders:

Douglas Mulhall, Naren Vyavahare

Number of Employees:

1-10

Last Funding Date:

2023-11-03

IPO Status:

Private

Industries:

© 2025 bioDAO.ai